Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

Louis Fehrenbacher, Alexander I. Spira, Marcus D. Ballinger et al. · The Lancet · 2016

Cited by 2,751 works. doi:10.1016/s0140-6736(16)00587-0

Authors

References